Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Clinuvel Pharmaceuticals Ltd (CLVLF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.8200 +0.0000    +0.00%
- Closed. Currency in USD ( Disclaimer )
  • Volume: 1,530
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 9.8200 - 9.8200
Type:  Equity
Market:  United States
Clinuvel Pharmaceuticals 9.8200 +0.0000 +0.00%

CLVLF Share Price Overview

 
Assess today's live Clinuvel Pharmaceuticals Ltd (CUV) share price, performance and insights using our live Sydney: CUV stock exchange data.

Analyse the historical data and Clinuvel Pharmaceuticals Ltd share price performance charts on this page. Our technical summary section provides analysis on Clinuvel Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Clinuvel Pharmaceuticals (CUV) stock price today with other investors in the Clinuvel Pharmaceuticals ASX share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current ASX CUV share price (ISIN: AU000000CUV3) to enhance your trading decisions with our free investment tools and resources.

What Is the Clinuvel Pharmaceuticals Ltd Share Price Today?
The Clinuvel Pharmaceuticals share price today is 9.8200.

What Is the Stock Symbol for Clinuvel Pharmaceuticals Ltd
The stock symbol (or 'ticker') for Clinuvel Pharmaceuticals Ltd is "CUV."

What Stock Exchange Does Clinuvel Pharmaceuticals Ltd Trade On?
Clinuvel Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.

Is Clinuvel Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Clinuvel Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close9.82
Day's Range9.82 - 9.82
Revenue81.76M
Open9.82
52 wk Range8.57 - 13.145
EPS0.609
Volume1,530
Market Cap479.18M
Dividend (Yield)N/A (N/A)
Average Volume (3m)1,383
P/E Ratio23.97
Beta0.772
1-Year Change - 24.69%
Shares Outstanding50,107,765
Next Earnings DateN/A
What is your sentiment on Clinuvel Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Neutral Sell Sell
Technical Indicators Strong Buy Strong Buy BUY BUY Strong Sell
Summary Strong Buy Strong Buy Neutral Neutral Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Homing Pigeon 1M 1 Mar 24
Tri-Star Bearish 5H 10 Feb 21, 2024 19:00
Tri-Star Bearish 1W 11 Dec 24, 2023
Tri-Star Bearish 1H 11 Feb 21, 2024 20:00
Tri-Star Bearish 15 11 Feb 21, 2024 20:15

Clinuvel Pharmaceuticals Ltd Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Sydney 14.57 14.57 14.63 49,264 -2.80% AUD  
  OTC Markets 9.464 0.000 0.000 133 -2.99% USD  
  OTC Markets 9.8200 0.0000 0.0000 1,530 +0.00% USD  

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Barclays 201.75 202.90 199.08 -2.25 -1.10% 11.86M 09:34:37  
  AstraZeneca 11,988.0 12,144.0 11,960.0 -38.0 -0.32% 223.96K 09:34:37  
  Legal & General 235.96 236.40 234.40 +3.16 +1.36% 1.99M 09:34:39  
  Anglo American 2,525.1 2,569.3 2,525.0 -34.9 -1.36% 984.54K 09:34:28  
  Rolls-Royce Holdings 411.10 414.90 409.20 +5.40 +1.33% 3.29M 09:34:51  
  Lloyds Banking 51.68 52.00 51.08 +0.48 +0.94% 21.53M 09:34:34  
  IAG 178.40 179.00 176.80 +2.25 +1.28% 2.21M 09:34:50  
  HSBC 662.30 665.50 662.30 +0.40 +0.06% 2.08M 09:34:29  
  J Sainsbury 258.68 261.39 258.39 +2.08 +0.81% 688.22K 09:34:55  
  BAE Systems 1,314.00 1,330.00 1,307.00 -6.00 -0.46% 1.19M 09:34:51  

%SHORT_NAME% Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company’s pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. The company was founded in 1987 and is headquartered in Melbourne, Australia.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CUV Price Commentary

Write your thoughts about Clinuvel Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email